* Conmed Corp CNMD.N reported quarterly adjusted earnings
of
$1.34 per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of
$1.06. The mean expectation of seven analysts for the quarter
was for earnings of $1.20 per share. Wall Street expected
results to range from $1.17 to $1.21 per share.
* Revenue rose 5.8% to $345.94 million from a year ago;
analysts
expected $341.01 million.
* Conmed Corp's reported EPS for the quarter was $1.08.
* The company reported quarterly net income of $33.75
million.
* Conmed Corp shares had risen by 6.5% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Conmed Corp is
$80.00
This summary was machine generated from LSEG data February 5 at
10:52 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 1.20 1.34 Beat
Sep. 30 2024 0.99 1.05 Beat
Jun. 30 2024 0.91 0.98 Beat
Mar. 31 2024 0.74 0.79 Beat